NASDAQ · Biotechnology

GRDX (GRDX) Stock

$2.90 -4.92% NASDAQ: GRDX Healthcare

Valuation

MetricValue
Price$2.90
Market Cap$9.75M
P/E Ratio-0.92
P/B Ratio0.54
P/S Ratio356.12
EPS (TTM)$-4.16
52-Week High$6.93
52-Week Low$1.08
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-29.17%
ROA-14.29%
ROCE-24.14%
Gross Margin-33.99%
Operating Margin-195.40%
Net Margin-180.78%
Debt/Equity0.10
Current Ratio0.20

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-59.0M$-13.0M$-16.0M$-16.0M$-7.0M
Net Profit$-59.0M$-15.0M$-16.0M$-18.0M$-7.0M
EPS$-27544.98$-407.37$-46.96$-5.33$-4.16
Op Margin————-19540.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.0M$5.0M$7.0M$85.0M$49.0M
Total Liabilities$20.0M$3.0M$3.0M$28.0M$20.0M
Cash$8.0M$1.0M$4.0M$0$1.0M
Borrowings$1.0M$1.0M$1.0M$0$2.0M

Latest News

GridAI Technologies Corp. to Present at the Market Movers Investor Summit TMX Newsfile · Apr 29, 2026 GridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing TMX Newsfile · Apr 28, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-32.0M$-22.0M$-12.0M$-9.0M$-6.0M
Investing Cash Flow$-21.0M$0$-1.0M$0$0
Financing Cash Flow$5.0M$-7.0M$0$0$0
Net Cash Flow$2.0M$-7.0M$2.0M$-4.0M$1.0M
Free Cash Flow$-43.0M$-22.0M$-13.0M$-9.0M$-6.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-44.17%
Quick Ratio0.17
Interest Coverage—
Return 1Y192.68%
Return 3Y-91.85%
Return 5Y-100.00%

Ownership

Insiders Held15.55%
Institutions Held5.19%
Institutions Float Held6.15%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC183,8002026-03-31
Federation Des Caisses Desjardins Du Quebec47,8002026-03-31
Geode Capital Management, LLC33,2702026-03-31
State Street Corporation23,4462026-03-31
Vanguard Capital Management LLC18,2932026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALLR $1.39 -0.71% -1.91 $22.12M 0.00%
ASBP $7.26 +3.13% -0.74 $837601 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%

About GRDX

GRDX is led by CEO Jason David Sawyer, employs 2 people, headquartered in US, publicly traded since 2016.

GRDX stock trades at $2.90 with a market capitalization of $9.75M. The stock is valued at a price-to-earnings (P/E) ratio of -0.92, price-to-book of 0.54, price-to-sales of 356.12. Over the past 52 weeks the stock has ranged between $1.08 and $6.93, and currently trades 58.1% below its 52-week high.

On profitability, GRDX generates a return on equity (ROE) of -29.17%, return on capital employed of -24.14%, an operating margin of -195.40%, a net profit margin of -180.78%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides